Improving access to affordable inhaled medicines – the role of clinical standards

Dr Shami Jayasooriya , University of Sheffield, UK


The majority of people with asthma can be managed effectively provided international asthma management recommendations (e.g., the Global Initiative for Asthma strategy) can be implemented. Unfortunately, this is often not the case in low- and middle-income countries, where limited access to affordable, quality diagnostic tests and treatments restrict the provision of effective asthma care. There are gaps between what is described in the currently available asthma management recommendations and the reality of what is typically available and affordable. We have therefore defined clinical standards tailored to the specific challenges of managing asthma in these settings.


A panel of 52 experts representing 31 countries participated in a two-stage Delphi process to establish and reach a consensus on clinical standards for the diagnosis and management of asthma in low- and middle- income countries.


18 clinical standards were defined. Standards 1-13 for contexts where WHO essential inhaled medicines are accessible and standards 14-18 for settings where these is no access to inhaled medicines. Please see article now in press for standards. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443788/pdf/i1815-7920-27-9-658.pdf


These first consensus-based clinical standards for asthma management in low- and middle- income countries are intended to help clinicians provide the most effective care for people in resource-limited settings.


  • Jayasooria S et al. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries. Int J Tuberc Lung Dis 2023;27(8):1-10


GAN gratefully acknowledges funding from the University of Auckland and Wellcome (Grant number 203919/Z/16/Z) as well as sponsorship from AstraZeneca and GlaxoSmithKline that has helped to make the GAN Symposium 2024 possible. We thank the speakers and the organisations they represent for their contributions including securing their own funding to enable their participation. The Symposium programme was developed independently by the GAN Steering Group.

Attention GAN Collaborators

Our network has been targeted by an email scam. If you receive any unusual requests for assistance from any of the steering group members, please ignore it.

These emails are a common scam that has also targeted many other organisations. Please note we will never make any request for financial assistance from our collaborators. If you have any questions please contact us at info@globalasthmanetwork.org